Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, a pivotal Investigational Device ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...

A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) ...

Senior guard Myles Stute has been diagnosed with a left lower leg deep vein thrombosis (blood clot) and will be out indefinitely, the South Carolina men’s basketball team announced Tuesday night. Deep ...

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

BAY-3018250 is under clinical development by Bayer and currently in Phase II for Deep Vein Thrombosis (DVT). According to GlobalData, Phase II drugs for Deep Vein Thrombosis (DVT) have a 71% phase ...